Xylanase, glucanase and xyloglucanase from Trichoderma citrinoviride DSM 33578 (4a39) for laying hens and piglets until 1 January 2036: three colorimetric methods on azurine substrates, 1500 EPU, 100 CU and 100 XGU/kg; batches had a ratio of about 7:1:1 instead of 15:1:1

Commission Implementing Regulation (EU) 2025/2503, published on 12 December 2025, authorises until 1 January 2036 a preparation of three enzymes produced by a non-genetically modified strain of Trichoderma citrinoviride DSM 33578 (holder: Huvepharma EOOD, product Huvezym® neXo) as a digestibility enhancer for poultry other than poultry for fattening and reared, and for pigs other than sows — those categories had already been authorised. After its opinions of 2022 and 2024, EFSA only in its opinion of 6 May 2025, based on new trials in laying hens and weaned piglets, considered the additive potentially efficacious in all poultry and all porcine species. The Polish title of the act reads “glwukanazy” (a typo).

Source: Commission Implementing Regulation (EU) 2025/2503 of 11 December 2025 concerning the authorisation of a preparation of endo-1,4-beta-xylanase, endo-1,4-beta-glucanase and xyloglucan-specific-endo-beta-1,4-glucanase produced with Trichoderma citrinoviride DSM 33578 as a feed additive for poultry other than poultry for fattening, poultry reared for laying and reared for breeding and porcine species other than sows of all Suidae species (holder of authorisation: Huvepharma EOOD)

Lab-News